Hospital Nuestra Senora De Sonsoles
- Address
- lock Available on a paid plan
Oncology – Neoplasms
The Servicio de Oncología at Hospital Nuestra Senora De Sonsoles focuses on Neoplasms, with a particular emphasis on c-Met overexpressing EGFR wildtype non-squamous non‑small cell lung cancer. The trials are designed to evaluate a new targeted therapy compared with standard chemotherapy, aiming to improve outcomes for patients with this molecular profile.
- Evaluation of a c-Met directed antibody‑drug conjugate
- Direct comparison with docetaxel chemotherapy
- Inclusion of previously treated non‑squamous NSCLC participants
The primary goal is to extend progression‑free survival and overall survival for individuals carrying the c-Met high‑expressing, EGFR wildtype tumor subtype, potentially offering a new therapeutic avenue after standard treatments have failed.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 5 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1LETI Pharma S.L.U.2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1LETI Pharma S.L.U.2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Nuestra Senora De Sonsoles
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of EVO756 Potassium in Adults with Moderate to Severe Chronic Spontaneous Urticaria: A Randomized, Double-Blind, Placebo-Controlled Study | Evommune Inc. | Phase II | Not Recruiting | — | Jun 2026 |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified | 2 | Unknown | 2021-05-11 | 2024-08-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.